• 1
    Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 17251730.
  • 2
    Kasiske BL, Cangro CB, Hariharan S et al. The evaluation of renal transplant candidates: Clinical practice guidelines. Am J Transplant 2001; 2: S5S95.
  • 3
    US Renal Data System: USRDS 2004 Annual Data Report. Bethesda , MD : National Institute of Diabetes and Digestive and Kidney Diseases .
  • 4
    Anavekar NS, McMurray JJ, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 12851295
  • 5
    Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 12961305.
  • 6
    Gaston RS, Danovitch GM, Adams PL et al. The report of a national conference on the wait list for renal transplantation. Am J Transplant 2003; 3: 775785.
  • 7
    Gaston RS, Basadonna G, Cosio FG et al. Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report. Am J Kidney Dis 2004; 44: 529542.
  • 8
    Herzog CA, Ma JZ, Collins AJ. Long-term survival of renal transplant recipients in the United States after acute myocardial infarction. Am J Kidney Dis 2000; 36: 145152.
  • 9
    Vasan RS, Sullivan LM, Wilson PW et al. Relative importance of borderline and elevated levels of coronary heart disease risk factors. Ann Intern Med 2005; 142: 393402.
  • 10
    Jardine AG. Pre-transplant management of end-stage renal disease patients to minimise post-transplant risk. Transplantation 2000; 70: S46S50.
  • 11
    Meier-Kriesche HU, Baliga R, Kaplan B. Decreased renal function is a strong risk factor for cardiovascular death after renal transplantation. Transplantation 2003; 75: 12911295.
  • 12
    Sharma R, Pellerin D, Gaze DC et al. Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 22072214.
  • 13
    Rabbat CG, Treleaven DJ, Russell JD, Ludwin D, Cook DJ. Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: A meta-analysis. J Am Soc Nephrol 2003; 14: 431439.
  • 14
    Ashley EA, Raxwal V, Finlay M, Froelicher V. Diagnosing coronary artery disease in diabetic patients. Diabetes Metab Res Rev 2002; 18: 201208.
  • 15
    De Lima JJ, Sabbaga E, Vieira ML et al. Coronary angiography is the best predictor of events in renal transplant candidates compared with non-invasive testing. Hypertension 2003; 42: 263275.
  • 16
    Marwick TH, Lauer MS, Lobo A, Nally J, Braun W. Use of dobutamine stress echocardiography for cardiac risk stratification of patients with chronic renal failure. J Intern Med 1998; 244: 155161.
  • 17
    Gill JS, Ma I, Landsberg DL, Johnson N, Levin A. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol 2005; 16: 808816.
  • 18
    The Veterans Administration Coronary Artery Bypass Surgery Co-operative Study Group. Eleven-year survival in the veterans administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 13331339.
  • 19
    Manske CL, Wang Y, Rector T, Wilson RF, White CW. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992; 340: 9981002.
  • 20
    Eagle KA, Coley CM, Newell JB et al. Combining clinical and thallium data optimises preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110: 859866.
  • 21
    McFalls EO, Ward HB, Moritz TE et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351: 27952804
  • 22
    Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 22072221.
  • 23
    Herzog CA, Ma JZ, Collins AJ. Long-term outcome of dialysis patients in the United States with coronary revascularisation procedures. Kidney Int 1999; 56: 324332.
  • 24
    Sadeghi HM, Stone GW, Grimes CL. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108: 27692775.
  • 25
    Herzog CA, Ma JZ, Collins AJ. Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures. Circulation 2004; 109: 28662871.
  • 26
    Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005; 353: 349361.
  • 27
    Ezekowitz J, McAlister FA, Humphries KH et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44: 15871592.
  • 28
    Holdaas H, Fellstrom B, Jardine AG et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 20242031.
  • 29
    Jardine A, Holdaas H, Fellström B et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT study. Am J Transplant 2004; 6: 988995.
  • 30
    Tokmakova MP, Skali H, Kenchaiah S et al. Chronic kidney disease, cardiovascular risk and response to angiotensin converting enzyme inhibition after myocardial infarction: The survival and ventricular enlargement (SAVE) study. Circulation 2004; 110: 36673673.